October 25, 2016 1:01 AM ET


Company Overview of Virobay Inc.

Key Executives for Virobay Inc.

NameBoard RelationshipsTitleAge
Robert F. G. Booth Ph.D.23 RelationshipsCo-Founder, Chairman, Chief Executive Officer, President and Secretary62
Heather Preston M.D.48 RelationshipsCo-Founder, Director, Chairperson of Nominating & Corporate Governance Committee and Member of Audit Committee50
Kyle C. Elrod B.A.No RelationshipsSenior Vice President of Project Management and Operations49
Elizabeth G. Shigezumi No RelationshipsHead of Clinical Operations and Clinical Trial Manager of Clinical Operations57

Virobay Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert F. G. Booth Ph.D. 23 RelationshipsVirobay Inc.62
Heather Preston M.D. 48 RelationshipsVirobay Inc.50
Thomas John Dietz Ph.D. 73 RelationshipsEiger BioPharmaceuticals, Inc.52
Daniel S. Janney MBA 63 RelationshipsAlta Partners LP51
Jeffrey W. Bird M.D., Ph.D. 94 RelationshipsVerinata Health, Inc.55
View All Board Members

Virobay Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Thomas John Dietz73 Relationships2 Executives
Compensation Committee Ph.D.Thomas John Dietz73 Relationships2 Executives
Nominating Committee M.D.Heather Preston48 Relationships2 Executives
Corporate Governance Committee M.D.Heather Preston48 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$355.4K
Compensation as of Fiscal Year 2013
Virobay Inc. CEO Compensation
Industry Average


Benitec Biopharma Limited to Appoint Jerel A. Banks to the Board
October 23, 2016 11:06 PM ET
Nordic Nanovector ASA Announces Board Changes
October 22, 2016 7:48 PM ET
4SC AG Announces Executive Changes
October 21, 2016 9:18 AM ET
Rosetta Genomics Ltd. Appoints Mark R. Willig as Chief Commercial Officer
October 20, 2016 12:40 PM ET
ChemoCentryx Appoints Henry A. McKinnell, Jr. to Board of Directors
October 20, 2016 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Virobay Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.